No Longer Draft, Senate Mandatory Supplement Registration Bill Gets Flood Of Opposition

Some stakeholders have supported mandatory listing but they join opponents questioning legislation also authorizing FDA to prohibit sales of products compliant with manufacturing and labeling regulations but deficient, incomplete or late with registration information required for the agency.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation